Brokerages predict that Genesco Inc. (NYSE:GCO) will report $892.17 million in sales for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Genesco’s earnings, with estimates ranging from $869.00 million to $906.50 million. Genesco posted sales of $883.17 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 1%. The business is expected to announce its next earnings results on Friday, March 9th.
On average, analysts expect that Genesco will report full year sales of $892.17 million for the current year, with estimates ranging from $2.85 billion to $2.88 billion. For the next fiscal year, analysts anticipate that the business will report sales of $2.88 billion per share, with estimates ranging from $2.85 billion to $2.91 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that follow Genesco.
Genesco (NYSE:GCO) last announced its earnings results on Friday, December 1st. The company reported $1.02 EPS for the quarter, missing the consensus estimate of $1.12 by ($0.10). Genesco had a positive return on equity of 6.93% and a negative net margin of 4.24%. The firm had revenue of $716.80 million during the quarter, compared to analyst estimates of $706.58 million. During the same quarter in the previous year, the business earned $1.28 earnings per share. The business’s quarterly revenue was up .8% compared to the same quarter last year.
Genesco (NYSE:GCO) opened at $35.75 on Thursday. Genesco has a fifty-two week low of $20.90 and a fifty-two week high of $63.50. The company has a market cap of $679.04, a PE ratio of 10.90, a price-to-earnings-growth ratio of 1.11 and a beta of 1.32. The company has a quick ratio of 0.47, a current ratio of 2.31 and a debt-to-equity ratio of 0.29.
A number of hedge funds and other institutional investors have recently bought and sold shares of GCO. Northern Trust Corp lifted its stake in Genesco by 47.5% in the second quarter. Northern Trust Corp now owns 586,814 shares of the company’s stock valued at $19,893,000 after acquiring an additional 188,906 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Genesco by 635.0% in the third quarter. JPMorgan Chase & Co. now owns 190,388 shares of the company’s stock valued at $5,026,000 after acquiring an additional 164,485 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in Genesco by 373.2% in the third quarter. Russell Investments Group Ltd. now owns 188,169 shares of the company’s stock valued at $5,004,000 after acquiring an additional 148,403 shares during the last quarter. Heartland Advisors Inc. acquired a new stake in Genesco in the fourth quarter valued at approximately $3,461,000. Finally, Monarch Partners Asset Management LLC acquired a new stake in Genesco in the fourth quarter valued at approximately $3,241,000. Hedge funds and other institutional investors own 97.99% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/08/brokerages-anticipate-genesco-inc-gco-will-post-quarterly-sales-of-892-17-million.html.
Genesco Company Profile
Genesco Inc is a retailer and wholesaler of footwear, apparel and accessories. The Company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group and Licensed Brands. It relies on independent third-party manufacturers for production of its footwear products sold at wholesale.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.